# EpicentRx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/epicentrx

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.epicentrx.com
- Total disclosed funding: $2.3M
- Latest round: Series B (Mar 27, 2008)
- Investors on record: 1

## About

Founded in 2002 and based in California, US, EpicentRx Inc., formerly known as RadioRx, Inc., operates as a clinical-stage immuno-oncology platform that develops anticancer compounds for immunotherapy of cancer patients and chemo/radioprotection of normal tissues. The company advances a smart virus program that eliminates tumors and prevents them from returning.

## Funding rounds

- Series B, Mar 27, 2008, $2.3M — InterWest Partners

## Investors

- InterWest Partners (https://capitalatlas.ai/funds/interwest-partners) — Series B